<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38225587</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>17</Day></DateCompleted><DateRevised><Year>2024</Year><Month>01</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2334</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jan</Month><Day>15</Day></PubDate></JournalIssue><Title>BMC infectious diseases</Title><ISOAbbreviation>BMC Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Characterisation, symptom pattern and symptom clusters from a retrospective cohort of Long COVID patients in primary care in Catalonia.</ArticleTitle><Pagination><StartPage>82</StartPage><MedlinePgn>82</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">82</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12879-023-08954-x</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Around 10% of people infected by SARS-COV-2 report symptoms that persist longer than 3 months. Little has been reported about sex differences in symptoms and clustering over time of non-hospitalised patients in primary care settings.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This is a descriptive study of a cohort of mainly non-hospitalized patients with a persistence of symptoms longer than 3 months from the clinical onset in co-creation with the Long Covid Catalan affected group using an online survey. Recruitment was from March 2020 to June 2021. Exclusion criteria were being admitted to an ICU, &lt;&#x2009;18&#x2009;years of age and not living in Catalonia. We focused on 117 symptoms gathered in 18 groups and performed cluster analysis over the first 21&#x2009;days of infection, at 22-60&#x2009;days, and&#x2009;&#x2265;&#x2009;3&#x2009;months.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We analysed responses of 905 participants (80.3% women). Median time between symptom onset and the questionnaire response date was 8.7&#x2009;months. General symptoms (as fatigue) were the most prevalent with no differences by sex, age, or wave although its frequency decreased over time (from 91.8 to 78.3%). Dermatological (52.1% in women, 28.5% in men), olfactory (34.9% women, 20.9% men) and neurocognitive symptoms (70.1% women, 55.8% men) showed the greatest differences by sex. Cluster analysis showed five clusters with a predominance of Taste &amp; smell (24.9%) and Multisystemic clusters (26.5%) at baseline and _Multisystemic (34.59%) and Heterogeneous (24.0%) at &#x2265;3&#x2009;months. The Multisystemic cluster was more prevalent in men. The Menstrual cluster was the most stable over time, while most transitions occurred from the Heterogeneous cluster to the Multisystemic cluster and from Taste &amp; smell to Heterogeneous.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">General symptoms were the most prevalent in both sexes at three-time cut-off points. Major sex differences were observed in dermatological, olfactory and neurocognitive symptoms. The increase of the Heterogeneous cluster might suggest an adaptation to symptoms or a non-specific evolution of the condition which can hinder its detection at medical appointments. A carefully symptom collection and patients' participation in research may generate useful knowledge about Long Covid presentation in primary care settings.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Torrell</LastName><ForeName>Gemma</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Centre d'Atenci&#xf3; Prim&#xe0;ria Les Indianes, Ger&#xe8;ncia Territorial de Barcelona, Institut Catal&#xe0; de la Salut, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Puente</LastName><ForeName>Diana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain. dpuente@idiapjgol.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universitat Aut&#xf2;noma de Barcelona, Cerdanyola del Vall&#xe8;s, Spain. dpuente@idiapjgol.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS) (RD21/0016/0029) Insitituto de Salud Carlos III, Madrid, Spain. dpuente@idiapjgol.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacques-Avi&#xf1;&#xf3;</LastName><ForeName>Constanza</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carrasco-Ribelles</LastName><ForeName>Lucia A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS) (RD21/0016/0029) Insitituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unitat de Suport a la Recerca Metropolitana Nord, Institut Universitari d'Investigaci&#xf3; en Atenci&#xf3; Prim&#xe0;ria Jordi Gol (IDIAP Jordi Gol), Matar&#xf3;, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Grup de REcerca en Impacte de les Malalties Cr&#xf2;niques i les seves Traject&#xf2;ries (GRIMTra), (2021 SGR 01537), Institut Universitari d'Investigaci&#xf3; en Atenci&#xf3; Prim&#xe0;ria Jordi Gol (IDIAPJGol), 08008, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Viol&#xe1;n</LastName><ForeName>Concepci&#xf3;</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Universitat Aut&#xf2;noma de Barcelona, Cerdanyola del Vall&#xe8;s, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS) (RD21/0016/0029) Insitituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unitat de Suport a la Recerca Metropolitana Nord, Institut Universitari d'Investigaci&#xf3; en Atenci&#xf3; Prim&#xe0;ria Jordi Gol (IDIAP Jordi Gol), Matar&#xf3;, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Grup de REcerca en Impacte de les Malalties Cr&#xf2;niques i les seves Traject&#xf2;ries (GRIMTra), (2021 SGR 01537), Institut Universitari d'Investigaci&#xf3; en Atenci&#xf3; Prim&#xe0;ria Jordi Gol (IDIAPJGol), 08008, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Direcci&#xf3; d'Atenci&#xf3; Prim&#xe0;ria Metropolitana Nord Institut Catal&#xe0; de Salut, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez-Jim&#xe9;nez</LastName><ForeName>Tom&#xe1;s</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universitat Aut&#xf2;noma de Barcelona, Cerdanyola del Vall&#xe8;s, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Royano</LastName><ForeName>Veronica</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Universitat Polit&#xe8;cnica de Catalunya BarcelonaTech (UPC), Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Members of the Col&#xb7;lectiu d'Afectades i Afectats Persistents per COVID-19 a Catalunya, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cant&#xf3;n</LastName><ForeName>Alba Molina</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Members of the Col&#xb7;lectiu d'Afectades i Afectats Persistents per COVID-19 a Catalunya, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Medina-Perucha</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodr&#xed;guez-Giralt</LastName><ForeName>Israel</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Internet Interdisciplinary Institute (IN3), Universitat Oberta de Catalunya, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berenguera</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universitat Aut&#xf2;noma de Barcelona, Cerdanyola del Vall&#xe8;s, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS) (RD21/0016/0029) Insitituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Infect Dis</MedlineTA><NlmUniqueID>100968551</NlmUniqueID><ISSNLinking>1471-2334</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011320" MajorTopicYN="N">Primary Health Care</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cluster analysis</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Participatory research</Keyword><Keyword MajorTopicYN="N">Post-COVID-19 syndrome</Keyword><Keyword MajorTopicYN="N">Primary health care</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>17</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>16</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>15</Day><Hour>23</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38225587</ArticleId><ArticleId IdType="pmc">PMC10789045</ArticleId><ArticleId IdType="doi">10.1186/s12879-023-08954-x</ArticleId><ArticleId IdType="pii">10.1186/s12879-023-08954-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ngozi AC. El peligro de la historia &#xfa;nica. Penguin Random House; 2018.</Citation></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re&#x2019;em Y, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine [Internet]. 2021;38:101019. Available from: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F; Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324(6):603&#x2013;5. 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Callard F, Perego E. How and why patients made Long Covid.&#xa0;Social Science &amp; Medicine&#xa0;[Internet]. 2021;268:113426. Available from: 10.1016/j.socscimed.2020.113426.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4):e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Lund LC, Hallas J, Nielsen H, Koch A, Mogensen SH, Brun NC, et al. Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a Danish population-based cohort study. Lancet Infect Dis. 2021;21(10):1373&#x2013;1382. doi: 10.1016/S1473-3099(21)00211-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00211-5</ArticleId><ArticleId IdType="pmc">PMC8110209</ArticleId><ArticleId IdType="pubmed">33984263</ArticleId></ArticleIdList></Reference><Reference><Citation>Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK - Office for National Statistics [Internet]. [cited 2022 Jul 15]. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/7july2022</Citation></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global Prevalence of Post COVID-19 Condition or Long COVID: A Meta-Analysis and Systematic Review 2 Running Title: Post COVID-19 Condition Meta-Analysis 3 4. J Infect Dis. 2022;(jiac136):1&#x2013;32. Available from: https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 11(1):16144. 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown DA, Brien O. Conceptualising Long COVID as an episodic health condition commentary handling editor Seye Abimbola. BMJ Glob Heal. 2021;6:7004.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8460526</ArticleId><ArticleId IdType="pubmed">34551971</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xed;ez Ant&#xf3;n JM, Blanco J, Bassat Q, Sarukhan A, Campins M, Guerri R, et al. Post-acute COVID syndrome (PACS): definition, impact and management a report of the multidisciplinary collaborative Group for the Scientific Monitoring of COVID-19 (GCMSC) members of the GCMSC group: Gema M Lled&#xf3; (invited contributor), Jacobo Sellares (invited contributor), Carlos Brotons, Mireia Sans. 2021 Available from: http://hdl.handle.net/2445/178471</Citation></Reference><Reference><Citation>Tejerina F, Catalan P, Rodriguez-Grande C, Adan J, Rodriguez-Gonzalez C, Mu&#xf1;oz P, et al. Post-COVID-19 syndrome. SARS-CoV-2 RNA detection in plasma, stool, and urine in patients with persistent symptoms after COVID-19. BMC Infect Dis. 2022;22(1):1&#x2013;8. doi: 10.1186/s12879-022-07153-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07153-4</ArticleId><ArticleId IdType="pmc">PMC8892394</ArticleId><ArticleId IdType="pubmed">35240997</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB, Howe A, Munier CML, Patel SK, et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022;23(2):210&#x2013;216. doi: 10.1038/s41590-021-01113-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero-Duarte &#xc1;, Rivera-Izquierdo M, Guerrero-Fern&#xe1;ndez de Alba I, P&#xe9;rez-Contreras M, Fern&#xe1;ndez-Mart&#xed;nez NF, Ruiz-Montero R, et al. Sequelae, persistent symptomatology and outcomes after COVID-19 hospitalization: the ANCOHVID multicentre 6-month follow-up study. BMC Med. 2021 19(1):1&#x2013;13. Available from: https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-021-02003-7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8134820</ArticleId><ArticleId IdType="pubmed">34011359</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang EY, Mao T, Klein J, Dai Y, Huck JD, Jaycox JR, et al. Diverse functional autoantibodies in patients with COVID-19. Nature. 2021;595:283&#x2013;288. doi: 10.1038/s41586-021-03631-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03631-y</ArticleId><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Kit Yeoh Y, Zuo T, Chung-Yan Lui G, Zhang F, Liu Q, Li AY, et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 2021;70(4):698&#x2013;706. doi: 10.1136/gutjnl-2020-323020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323020</ArticleId><ArticleId IdType="pmc">PMC7804842</ArticleId><ArticleId IdType="pubmed">33431578</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Y, Liu J, Zhang D, Xu Z, Ji J, Wen C. Cytokine storm in COVID-19: the current evidence and treatment strategies. Front Immunol. 2020;11:1&#x2013;13. doi: 10.3389/fimmu.2020.01708.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01708</ArticleId><ArticleId IdType="pmc">PMC7365923</ArticleId><ArticleId IdType="pubmed">32754163</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, VanElzakker MB. Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent Symptoms. Front Microbiol. 2021;23:1494.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J, Wood J, Jaycox J, Lu P, Dhodapkar RM, Gehlhausen JR, et al. Distinguishing features of Long COVID identified through immune profiling. medRxiv. 2022;623(7985):139&#x2013;148.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. Attributes and predictors of long COVID. Nat Med. 27(4):626&#x2013;31. 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziauddeenid N, Gurdasani D, O&#x2019;hara ME, Hastie C, Roderick P, Yao G, et al. Characteristics and impact of Long Covid: Findings from an online survey. PloS one. 2022;17(3):e0264331. doi: 10.1371/journal.pone.0264331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0264331</ArticleId><ArticleId IdType="pmc">PMC8903286</ArticleId><ArticleId IdType="pubmed">35259179</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale KM, et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. 2022;28(8):1706&#x2013;1714. doi: 10.1038/s41591-022-01909-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Maglietta G, Diodati F, Puntoni M, Lazzarelli S, Marcomini B, Patrizi L, et al. Clinical medicine prognostic factors for post-COVID-19 syndrome: a systematic review and Meta-analysis. J Clin Med. 2022;11(6):1541. doi: 10.3390/jcm11061541.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11061541</ArticleId><ArticleId IdType="pmc">PMC8948827</ArticleId><ArticleId IdType="pubmed">35329867</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith PB, Easterbrook MJ, Al-Selim H, Miu V, Lun C, Koc Y, et al. Sex Differences in Self-Construal and in Depressive Symptoms: Predictors of Cross-National Variation. J Cross Cult Psychol. 51(7-8):616&#x2013;35. 10.1177/0022022120939655.</Citation></Reference><Reference><Citation>Estiri H, Strasser ZH, Brat GA, Semenov YR, Patel CJ, Murphy SN. Evolving phenotypes of non-hospitalized patients that indicate long COVID. BMC Med. 2021;19(1):1&#x2013;10. doi: 10.1186/s12916-021-02115-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02115-0</ArticleId><ArticleId IdType="pmc">PMC8474909</ArticleId><ArticleId IdType="pubmed">34565368</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenny G, Mccann K, O&#x2019;brien C, Savinelli S, Tinago W, Yousif O, et al. Identification of Distinct Long COVID Clinical Phenotypes Through Cluster Analysis of Self-Reported Symptoms.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8900926</ArticleId><ArticleId IdType="pubmed">35265728</ArticleId></ArticleIdList></Reference><Reference><Citation>Canas LS, Molteni E, Deng J, Sudre CH, Murray B, Kerfoot E, et al. Profiling post-COVID syndrome across different variants of SARS-CoV-2. medRxiv. 2022:2022&#x2013;07. Available from: https://www.medrxiv.org/content/10.1101/2022.07.28.22278159v1</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10187990</ArticleId><ArticleId IdType="pubmed">37202336</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacques-Avi&#xf1;&#xf3; C, Pons-Vigu&#xe9;s M, Elsie Mcghie J, Rodr&#xed;guez-Giralt I, Medina-Perucha L, Mahtani-Chugani V, et al. Participaci&#xf3;n p&#xfa;blica en los proyectos de investigaci&#xf3;n: formas de crear conocimiento colectivo en salud. Gac Sanit. 2020;34(2):200&#x2013;203. doi: 10.1016/j.gaceta.2019.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gaceta.2019.08.010</ArticleId><ArticleId IdType="pubmed">31785893</ArticleId></ArticleIdList></Reference><Reference><Citation>Servier C, Porcher R, Pane I, Ravaud P, Tran V-T. Trajectories of the evolution of post-COVID-19 condition, up to two years after symptoms onset. Int J Infect Dis. 2023;133:67&#x2013;74. doi: 10.1016/j.ijid.2023.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2023.05.007</ArticleId><ArticleId IdType="pmc">PMC10176960</ArticleId><ArticleId IdType="pubmed">37182548</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynberg E, Van Willigen HDG, Dijkstra M, Boyd A, Kootstra NA, Van Den Aardweg JG, et al. Evolution of coronavirus disease 2019 (COVID-19) Symptoms during the first 12 months after illness onset. Clin Infect Dis. 2022;75(1):E482&#x2013;E490. doi: 10.1093/cid/ciab759.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab759</ArticleId><ArticleId IdType="pmc">PMC8522402</ArticleId><ArticleId IdType="pubmed">34473245</ArticleId></ArticleIdList></Reference><Reference><Citation>Col&#xb7;lectiu d&#x2019;afectades i afectats persistents per la COVID-19 a Catalunya. Home [Internet] [cited 2022 Sep 19]. Available from: https://sites.google.com/xtec.cat/afectatspersistentscovid19/home</Citation></Reference><Reference><Citation>Greenhalgh T, Knight M, A&#x2019;Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020;370 Available from: https://www.bmj.com/content/370/bmj.m3026</Citation><ArticleIdList><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Assaf G, Davis H, McCorkell L, Akrami A, Wei H, Brooke O, et al. How does COVID-19 recovery actually looks like? [Internet]. 2020. Available from: https://patientresearchcovid19.com/research/report-1/</Citation></Reference><Reference><Citation>Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O&#x2019;neal L, et al. The REDCap consortium: building an International Community of Software Platform Partners Graphical Abstarct HHS public access. J Biomed Inf. 2019;95:103208. doi: 10.1016/j.jbi.2019.103208.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2019.103208</ArticleId><ArticleId IdType="pmc">PMC7254481</ArticleId><ArticleId IdType="pubmed">31078660</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377&#x2013;81. 10.1016/j.jbi.2008.08.010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2700030</ArticleId><ArticleId IdType="pubmed">18929686</ArticleId></ArticleIdList></Reference><Reference><Citation>Ministerio de Sanidad. Contenido. Inf RENAVE no113 [Internet]. 2022 [cited 2022 Jul 15]; Available from: https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/documentos/COVID19_Estrategia_vigilancia_y_control_e_indica</Citation></Reference><Reference><Citation>Chavent M, Kuentz-Simonet V, Labenne A, Saracco J. Multivariate Analysis of Mixed Data: The R Package PCAmixdata. 2014 Oct 23 [cited 2022 Sep 19]; Available from: https://cran.r-project.org/package=PCAmixdata</Citation></Reference><Reference><Citation>Karlis D, Saporta G, Spinakis A. A Simple Rule for the Selection of Principal Components. Commun Stat-Theory Methods. 2006;32(3):643&#x2013;666. doi: 10.1081/STA-120018556.</Citation><ArticleIdList><ArticleId IdType="doi">10.1081/STA-120018556</ArticleId></ArticleIdList></Reference><Reference><Citation>Bezdek JC, Ehrlich R, Full W. FCM: the fuzzy c-means clustering algorithm. Comput Geosci. 1984;10(2&#x2013;3):191&#x2013;203. doi: 10.1016/0098-3004(84)90020-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0098-3004(84)90020-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Tazzeo C, Rizzuto D, Calder&#xf3;n-Larra&#xf1;aga A, Roso-Llorach A, Marengoni A, Welmer A-K, et al. Multimorbidity patterns and risk of frailty in older community-dwelling adults: a population-based cohort study. Age Ageing. 2021;50:2183&#x2013;2191. doi: 10.1093/ageing/afab138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ageing/afab138</ArticleId><ArticleId IdType="pmc">PMC8581386</ArticleId><ArticleId IdType="pubmed">34228784</ArticleId></ArticleIdList></Reference><Reference><Citation>Viol&#xe1;n C, Fern&#xe1;ndez-Bertol&#xed;n S, Guisado-Clavero M, Foguet-Boreu Q, Valderas JM, Manzano JV, et al. Five-year trajectories of multimorbidity patterns in an elderly Mediterranean population using hidden Markov models. Sci Rep. 10(1):168799. 10.1038/s41598-020-73231-9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7547668</ArticleId><ArticleId IdType="pubmed">33037233</ArticleId></ArticleIdList></Reference><Reference><Citation>Guisado-Clavero M, Roso-Llorach A, L&#xf3;pez-Jimenez T, Pons-Vigu&#xe9;s M, Foguet-Boreu Q, Mu&#xf1;oz MA, et al. Multimorbidity patterns in the elderly: a prospective cohort study with cluster analysis. BMC Geriatr. 2018;18(1):1&#x2013;11. doi: 10.1186/s12877-018-0705-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-018-0705-7</ArticleId><ArticleId IdType="pmc">PMC5771078</ArticleId><ArticleId IdType="pubmed">29338690</ArticleId></ArticleIdList></Reference><Reference><Citation>Viol&#xe1;n C, Foguet-Boreu Q, Fern&#xe1;ndez-Bertol&#xed;n S, Guisado-Clavero M, Cabrera-Bean M, Formiga F, et al. Soft clustering using real-world data for the identification of multimorbidity patterns in an elderly population: cross-sectional study in a Mediterranean population. Available from: http://bmjopen.bmj.com/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6719769</ArticleId><ArticleId IdType="pubmed">31471439</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B, Greve-Isdahl Mohn K, Albert Brokstad K, Zhou F, Waag Linchausen D, Hansen B-A, et al. Long COVID in a prospective cohort of home-isolated patients. Nat Med. 27(9):1607&#x2013;13. 10.1038/s41591-021-01433-3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Hastie CE, Lowe DJ, McAuley A, Winter AJ, Mills NL, Black C, et al. Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland study. Nat Commun. 2022;13(1):1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9556711</ArticleId><ArticleId IdType="pubmed">36224173</ArticleId></ArticleIdList></Reference><Reference><Citation>Mateu L, Tebe C, Loste C, Santos JR, Llad&#xf3;s G, L&#xf3;pez C, et al. Determinants of the onset and prognosis of the post-COVID-19 condition: a 2-year prospective observational cohort study. Lancet Reg Heal&#x2013;Eur. 2023;33:100724. doi: 10.1016/j.lanepe.2023.100724.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2023.100724</ArticleId><ArticleId IdType="pmc">PMC10636281</ArticleId><ArticleId IdType="pubmed">37954002</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodr&#xed;guez Ledo P, Armenteros del Olmo L, Rodr&#xed;guez Rodr&#xed;guez E, G&#xf3;mez AF. Descripci&#xf3;n de los 201 s&#xed;ntomas de la afectaci&#xf3;n multiorg&#xe1;nica producida en los pacientes afectados por la COVID-19 persistente. Med Gen y Fam. 2021;10(2):60&#x2013;68. doi: 10.24038/mgyf.2021.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.24038/mgyf.2021.016</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-De-las-pe&#xf1;as C, Mart&#xed;n-Guerrero JD, Pellicer-Valero &#xd3;J, Navarro-Pardo E, G&#xf3;mez-Mayordomo V, Cuadrado ML, et al. Female sex is a risk factor associated with Long-term post-COVID related-Symptoms but not with COVID-19 Symptoms: the LONG-COVID-EXP-CM multicenter study. J Clin Med. 2022;11(2):1&#x2013;10. doi: 10.3390/jcm11020413.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11020413</ArticleId><ArticleId IdType="pmc">PMC8778106</ArticleId><ArticleId IdType="pubmed">35054108</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauvais-Jarvis F, Bairey Merz N, Barnes PJ, Brinton RD, Carrero JJ, DeMeo DL, et al. Sex and gender: modifiers of health, disease, and medicine. Lancet. 2020;396(10250):565&#x2013;582. doi: 10.1016/S0140-6736(20)31561-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31561-0</ArticleId><ArticleId IdType="pmc">PMC7440877</ArticleId><ArticleId IdType="pubmed">32828189</ArticleId></ArticleIdList></Reference><Reference><Citation>Barsky AJ, Peekna HM, Borus JF. Somatic symptom reporting in women and men. J Gen Intern Med. 2001;16(4):266&#x2013;75. 10.1046/j.1525-1497.2001.00229.x.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1495200</ArticleId><ArticleId IdType="pubmed">11318929</ArticleId></ArticleIdList></Reference><Reference><Citation>Scholz U, Bierbauer W, L&#xfc;scher J. Social Stigma, Mental Health, Stress, and Health-Related Quality of Life in People with Long COVID. Int J Environ Res Public Health. 2023;20(5):3927. doi: 10.3390/ijerph20053927.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph20053927</ArticleId><ArticleId IdType="pmc">PMC10001775</ArticleId><ArticleId IdType="pubmed">36900938</ArticleId></ArticleIdList></Reference><Reference><Citation>Pantelic M, Ziauddeen N, Boyes M, O&#x2019;Hara ME, Hastie C, Alwan NA. Long Covid stigma: estimating burden and validating scale in a UK-based sample. medRxiv. 2022;17(11):e0277317.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9683629</ArticleId><ArticleId IdType="pubmed">36417364</ArticleId></ArticleIdList></Reference><Reference><Citation>Damant RW, Rourke L, Cui Y, Lam GY, Smith MP, Fuhr DP, et al. Reliability and validity of the post COVID-19 condition stigma questionnaire: a prospective cohort study. eClinicalMedicine. 2023;55:101755. doi: 10.1016/j.eclinm.2022.101755.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101755</ArticleId><ArticleId IdType="pmc">PMC9694932</ArticleId><ArticleId IdType="pubmed">36447641</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelletier R, Choi J, Winters N, Eisenberg MJ, Bacon SL, Cox J, et al. Sex differences in clinical outcomes after premature acute coronary syndrome. Can J Cardiol. 2016;32(12):1447&#x2013;1453. doi: 10.1016/j.cjca.2016.05.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2016.05.018</ArticleId><ArticleId IdType="pubmed">27683172</ArticleId></ArticleIdList></Reference><Reference><Citation>Go&#xeb;rtz YMJ, Van Herck M, Delbressine JM, Vaes AW, Meys R, Machado FVC, et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res. 2020;6(4):00542&#x2013;02020. doi: 10.1183/23120541.00542-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00542-2020</ArticleId><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering AV, van Zon SK, Olde Hartman TC, Rosmalen JG. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet. 2022;400(10350):452. doi: 10.1016/S0140-6736(22)01214-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01214-4</ArticleId><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigfrid L, Cevik M, Jesudason E, Lim WS, Rello J, Amuasi J, et al. What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? - a harmonised, global longitudinal observational study protocol. BMJ Open. 2021;11(3):e043887. doi: 10.1136/bmjopen-2020-043887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-043887</ArticleId><ArticleId IdType="pmc">PMC7948153</ArticleId><ArticleId IdType="pubmed">33692181</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo P, Benito Ballesteros A, Yeung SP, Liu R, Saha A, Curtis L, et al. COVCOG 1: factors predicting physical, neurological and cognitive Symptoms in Long COVID in a community sample. A first publication from the COVID and cognition study. Front Aging Neurosci. 2022;14:1&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8968323</ArticleId><ArticleId IdType="pubmed">35370617</ArticleId></ArticleIdList></Reference><Reference><Citation>Kye Jyn Tan B, Han R, Zhao JJ, Kye Wen Tan N, Sen Hui Quah E, Jing-Wen Tan C, et al. Prognosis and persistence of smell and taste dysfunction in patients with covid-19: meta-analysis with parametric cure modelling of recovery curves. Bmj. 378 Available from: http://www.bmj.com/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9326326</ArticleId><ArticleId IdType="pubmed">35896188</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M, Manoharan L, Elkheir N, Cheng V, Dagens A, Hastie C, et al. Characterising long COVID: a living systematic review. BMJ Glob Heal. 2021;6(9):e005427. doi: 10.1136/bmjgh-2021-005427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Caspersen IH, Magnus P, Trogstad L. Excess risk and clusters of symptoms after COVID-19 in a large Norwegian cohort. Eur J Epidemiol. 2022;37(5):539&#x2013;548. doi: 10.1007/s10654-022-00847-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-022-00847-8</ArticleId><ArticleId IdType="pmc">PMC8872922</ArticleId><ArticleId IdType="pubmed">35211871</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M, Elliott J, Chadeau-Hyam M, Riley S, Darzi A, Cooke G, et al. Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat Commun. 2022;13(1):1957. doi: 10.1038/s41467-022-29521-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29521-z</ArticleId><ArticleId IdType="pmc">PMC9005552</ArticleId><ArticleId IdType="pubmed">35413949</ArticleId></ArticleIdList></Reference><Reference><Citation>Perumal R, Shunmugam L, Naidoo K, Abdool Karim SS, Wilkins D, Garzino-Demo A, et al. Long COVID: a review and proposed visualization of the complexity of long COVID. Front Immunol. 2023;14:1&#x2013;18. doi: 10.3389/fimmu.2023.1117464.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1117464</ArticleId><ArticleId IdType="pmc">PMC10157068</ArticleId><ArticleId IdType="pubmed">37153597</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottlieb M, Spatz ES, Yu H, Wisk LE, Elmore JG, Gentile NL, et al. Long COVID Clinical Phenotypes up to 6 Months After Infection Identified by Latent Class Analysis of Self-Reported Symptoms. In: Open Forum Infectious Diseases. Oxford University Press. p. ofad277. 10.1093/ofid/ofad277.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10327879</ArticleId><ArticleId IdType="pubmed">37426952</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M, Elliott J, Chadeau-Hyam M, Riley S, Darzi A, Cooke G, et al. Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat Commun. 13(1):1957. 10.1038/s41467-022-29521-z.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9005552</ArticleId><ArticleId IdType="pubmed">35413949</ArticleId></ArticleIdList></Reference><Reference><Citation>Caspersen IH, Trogstad L. Excess risk and clusters of symptoms after COVID-19 in a large Norwegian cohort. Eur J Epidemiol. 2022;37(5):539&#x2013;548. doi: 10.1101/2021.10.15.21265038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.10.15.21265038</ArticleId><ArticleId IdType="pmc">PMC8872922</ArticleId><ArticleId IdType="pubmed">35211871</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Pinto MD, Borelli JL, Mehrabadi MA, Abrihim H, Dutt N, et al. COVID Symptoms, Symptom Clusters, and Predictors for Becoming a Long-Hauler: Looking for Clarity in the Haze of the Pandemic. 2021;31(8):1390&#x2013;8. 10.1101/2021.03.03.21252086.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9510954</ArticleId><ArticleId IdType="pubmed">36154716</ArticleId></ArticleIdList></Reference><Reference><Citation>MAA A-N, Al-Alwany RR, Al-Rshoud FM, Abu-Farha RK, Zawiah M. Menstrual changes following COVID-19 infection: A cross-sectional study from Jordan and Iraq. PLoS One. 2022;17(6):e0270537. doi: 10.1371/journal.pone.0270537.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0270537</ArticleId><ArticleId IdType="pmc">PMC9242447</ArticleId><ArticleId IdType="pubmed">35767537</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran V-T, Porcher R, Pane I, Ravaud P. Course of post COVID-19 disease symptoms over time in the ComPaRe long COVID prospective e-cohort. Nat Commun. 13(1):1812. 10.1038/s41467-022-29513-z.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8983754</ArticleId><ArticleId IdType="pubmed">35383197</ArticleId></ArticleIdList></Reference><Reference><Citation>Babbar K, Martin J, Ruiz J, Parray AA, Sommer M. Menstrual health is a public health and human rights issue. Lancet Public Heal. 2022;7(1):e10&#x2013;e11. doi: 10.1016/S2468-2667(21)00212-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-2667(21)00212-7</ArticleId><ArticleId IdType="pmc">PMC8552814</ArticleId><ArticleId IdType="pubmed">34717798</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelin D, Margalit I, Nehme M, Bordas-Mart&#xed;nez J, Pistelli F, Yahav D, et al. Clinical medicine patterns of Long COVID Symptoms: a multi-center cross sectional study. J Clin Med. 2022;11:898. doi: 10.3390/jcm11040898.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11040898</ArticleId><ArticleId IdType="pmc">PMC8875229</ArticleId><ArticleId IdType="pubmed">35207171</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Pinto MD, Borelli JL, Mehrabadi MA, Abrihim H, Dutt N, et al. COVID Symptoms, Symptom Clusters, and Predictors for Becoming a Long-Hauler: Looking for Clarity in the Haze of the Pandemic. medRxiv Prepr Serv Heal Sci [Internet]. 2021 Mar 5 [cited 2022 Jul 18]; Available from: http://www.ncbi.nlm.nih.gov/pubmed/33688670.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9510954</ArticleId><ArticleId IdType="pubmed">36154716</ArticleId></ArticleIdList></Reference><Reference><Citation>Sylvester SV, Rusu R, Chan B, Bellows M, O&#x2019;keefe C, Nicholson S. Sex differences in sequelae from COVID-19 infection and in long COVID syndrome: a review. Curr Med Res Opin. 2022;38(8):1391&#x2013;1399. doi: 10.1080/03007995.2022.2081454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03007995.2022.2081454</ArticleId><ArticleId IdType="pubmed">35726132</ArticleId></ArticleIdList></Reference><Reference><Citation>Badsha MB, Mollah MNH, Jahan N, Kurata H. Robust complementary hierarchical clustering for gene expression data analysis by &#x3b2;-divergence. J Biosci Bioeng. 2013;116(3):397&#x2013;407. doi: 10.1016/j.jbiosc.2013.03.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbiosc.2013.03.010</ArticleId><ArticleId IdType="pubmed">23608734</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuzzy Clustering [Internet]. [cited 2023 Feb 6]. Available from: https://reference.wolfram.com/legacy/applications/fuzzylogic/Manual/12.html</Citation></Reference><Reference><Citation>Nehme M, Vetter P, Chappuis F, Kaiser L, Guessous I, Team for the CS et al. Prevalence of Post-COVID Condition 12 Weeks After Omicron Infection Compared With Negative Controls and Association With Vaccination Status. Clin Infect Dis. 2022;76(9):1567&#x2013;1575. doi: 10.1093/cid/ciac947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac947</ArticleId><ArticleId IdType="pubmed">36519381</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzolini E, Levi R, Sarti R, Pozzi C, Mollura M, Mantovani A, et al. Association Between BNT162b2 Vaccination and Long COVID After Infections Not Requiring Hospitalization in Health Care Workers. JAMA. 2022;328(7):676. doi: 10.1001/jama.2022.11691.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.11691</ArticleId><ArticleId IdType="pmc">PMC9250078</ArticleId><ArticleId IdType="pubmed">35796131</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>